Cns Pharmaceuticals logo

Cns Pharmaceuticals Share Price (NASDAQ: CNSP)

$6.2

-0.06

(-0.96%)

Last updated on

Check the interactive Cns Pharmaceuticals Stock chart to analyse performance

Cns Pharmaceuticals stock performance

as on August 30, 2025 at 1:28 am IST

  • Today's Low:$6.20
    Today's High:$6.39

    Day's Volatility :2.97%

  • 52 Weeks Low:$4.93
    52 Weeks High:$221.94

    52 Weeks Volatility :97.78%

Cns Pharmaceuticals Stock Returns

PeriodCns Pharmaceuticals IncIndex (Russel 2000)
3 Months
-46.75%
0.0%
6 Months
-75.8%
0.0%
1 Year
-92.95%
0.0%
3 Years
-100.0%
-4.7%

Cns Pharmaceuticals Inc Key Stats

Check Cns Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$6.26
Open
$6.39
Today's High
$6.39
Today's Low
$6.2
Market Capitalization
$3.6M
Today's Volume
$19.6K
52 Week High
$221.94
52 Week Low
$4.93
Revenue TTM
$0.0
EBITDA
$-15.6M
Earnings Per Share (EPS)
$2123.39
PE Ratio
0.0
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-350.08%

Stock Returns calculator for Cns Pharmaceuticals Stock including INR - Dollar returns

The Cns Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cns Pharmaceuticals investment value today

Current value as on today

₹12,127

Returns

₹87,873

(-87.87%)

Returns from Cns Pharmaceuticals Stock

₹93,157 (-93.16%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Cns Pharmaceuticals Stock

-20%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Cns Pharmaceuticals Stock from India on INDmoney has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Cns Pharmaceuticals Inc

  • Name

    Holdings %

  • UBS Group AG

    0.38%

  • Ground Swell Capital, LLC

    0.18%

  • Tower Research Capital LLC

    0.08%

Analyst Recommendation on Cns Pharmaceuticals Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Cns Pharmaceuticals(by analysts ranked 0 to 5 stars)

Cns Pharmaceuticals Share Price Target

What analysts predicted

Upside of 1254.84%

Target:

$84.00

Current:

$6.20

Cns Pharmaceuticals share price target is $84.00, a slight Upside of 1254.84% compared to current price of $6.20 as per analysts' prediction.

Cns Pharmaceuticals Stock Insights

  • Price Movement

    In the last 1 month, CNSP stock has moved down by -16.1%
  • CNSP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 163.1%
  • CNSP vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 212.6%

Cns Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Cns Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cns Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Cns Pharmaceuticals Inc logo
-17.01%
-75.8%
-92.95%
-100.0%
-100.0%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Cns Pharmaceuticals Inc

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.
Organization
Cns Pharmaceuticals
Employees
4
CEO
Mr. John Michael Climaco Esq., J.D.
Industry
Health Technology

Key Management of Cns Pharmaceuticals Inc

NameTitle
Mr. John Michael Climaco Esq., J.D.
CEO, President & Director
Mr. Christopher S. Downs CPA, CTP, FP&A
Chief Financial Officer
Dr. Sandra L. Silberman M.D., Ph.D.
Chief Medical Officer
Dr. Donald H. Picker Ph.D.
Chief Science Officer

Important FAQs about investing in CNSP Stock from India :

What is Cns Pharmaceuticals share price today?

Cns Pharmaceuticals share price today is $6.20 as on at the close of the market. Cns Pharmaceuticals share today touched a day high of $6.39 and a low of $6.20.

What is the 52 week high and 52 week low for Cns Pharmaceuticals share?

Cns Pharmaceuticals share touched a 52 week high of $221.94 and a 52 week low of $4.93. Cns Pharmaceuticals stock price today i.e. is closed at $6.20, lower by 97.21% versus the 52 week high.

How to invest in Cns Pharmaceuticals Stock (CNSP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Cns Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cns Pharmaceuticals Shares that will get you 0.2419 shares as per Cns Pharmaceuticals share price of $6.20 per share as on August 30, 2025 at 1:28 am IST.

What is the minimum amount required to buy Cns Pharmaceuticals Stock (CNSP) from India?

Indian investors can start investing in Cns Pharmaceuticals (CNSP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Cns Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Cns Pharmaceuticals share’s latest price of $6.20 as on August 30, 2025 at 1:28 am IST, you will get 1.6129 shares of Cns Pharmaceuticals. Learn more about fractional shares .

What are the returns that Cns Pharmaceuticals has given to Indian investors in the last 5 years?

Cns Pharmaceuticals stock has given -100.0% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?